- Supplier site
- Group of sites (click to zoom)
Scientist.com supplier network (site locations)

Research supplier
Drik
Drik is listed as a new startup research supplier in the Scientist.com network, with 3 sites in 1 country.
Sign in to Scientist.com to open this supplier in your organization's marketplace.
Search companies, drugs, suppliers and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Services
What this research supplier says it provides, as listed in the Scientist.com network.
Type of company: New startup
Bioimaging
- Luminescence Imaging Monitor biological processes and pathologies using reporter proteins such as firefly and Renilla luciferase.
- SPECT-CT and PET-CT Imaging Get images that combine the spatial context of metabolic or biochemical activity with an anatomic image.
Biomarkers
- Antioxidant Assays Use biochemical, cell-based or in vivo assays to measure total antioxidant capacity.
- Biomarker Discovery Identify a biomarker associated with disease progression of disease, effectiveness of therapy or diagnosis of disease or condition.
- Cell Migration Assays Measure chemotaxis, haptotaxis, transmigration and wound-healing.
- Cell Viability Measure changes in cell number, cell division, DNA content or a cell metabolism marker such as ATP levels.
- Hematoxylin & Eosin (H&E) Staining Visualize microscopic structures in cells or tissues.
- Histamine Release Assay Use in vivo or in vitro assays to measure the release of histamine in response to an allergen stimulation.
Show all 15 in Biomarkers
- In Vivo Apoptosis Detection Visualize and quantify apoptosis in real time.
- Interferon Gamma Release Assay Use in vivo or in vitro assays to measure the cell-mediated immune response to an infectious agent.
- Lipid Peroxidation Assay Use in vitro or in vivo assays to evaluate the effects of oxidative stress on lipid structure and function.
- Paraffin-based Histology Perform sectioning and histological analysis of wax-embedded samples.
- Pharmacodynamic Biomarkers Discovery Identify candidate biomarkers indicative of the therapeutic outcome of a drug-target interaction.
- Plaque Assays Determine infectious viral titer using plaque-forming units or purify viral stocks.
- Propidium Iodide FACS Analysis Use DNA staining and flow cytometry to analyze the cell cycle and detect apoptosis or cell proliferation.
- Special Stainings Use a variety of techniques for the selective visualization of specific tissue or cell types.
- TUNEL Assay Detect in situ DNA fragmentation.
Cell Culture and Characterization
- 3D Cell Culture Use a scaffold-based or scaffold-free format to grow three dimensional cell and tissue structures.
- Bacterial Cell Culture Culture and Grow bacterial cells.
- Cell and Tissue Histology Prepare and stain frozen, fixed and embedded (FFPE) tissue samples.
- Cell Culture Culture primary or immortalized cell lines.
- Explant Culture Culture cells obtained from a part or parts of an in vivo structure.
- Mycobacterium Screening Detect and distinguish between mycobacterium strains and species.
Show all 7 in Cell Culture and Characterization
- Organotypic Culture Co-culture different cells to enable in vitro growth of an in vivo tissue or organ equivalent.
Show all 120 services
Chemical and Compound Analysis
- Endotoxin Testing Use standard assays like LAL (Limulus Amebocyte Lysate), rFC (Recombinant Factor C), or MAT (Monocyte Activation Test) to detect and quantify the level of endotoxins in a sample
- UV-Spectroscopy Conduct sample analysis based on light absorption and transmission.
Chemical and Compound Testing
- Limulus Amebocyte Lysate (LAL) Test Detect bacterial endotoxins in raw materials used for the production of cosmetics products.
Clinical Consulting
- Product Testing Consulting Expert advice to evaluate the effectiveness, quality, and legitimacy of a given item or good.
Clinical Trials
- Bioequivalence Studies Assess the expected biological equivalence of two proprietary preparations of a drug.
Disease Models
- Acute Kidney Failure Models Measure therapeutic endpoints in animal models of acute kidney failure.
- Acute Liver Failure Models Measure therapeutic endpoints in animal models of acute liver failure.
- Acute Lung Injury Models Measure therapeutic endpoints in animal models of acute lung injury.
- Bacterial Infection Models Measure therapeutic endpoints in animal models of bacterial infection.
- Behavioral Testing Models Investigate sensory-motor and emotional functions, social behavior and day-night activity.
- Cardiovascular Metabolics Models Measure therapeutic endpoints in animal models of cardiovascular disorders.
Show all 20 in Disease Models
- Cognition Models Measure therapeutic endpoints in animal models of cognition.
- Drug-Induced Liver Injury (DILI) Toxicity Assays Use biochemical, cell-based or in vivo assays to measure toxicity from drug-induced liver injury.
- Excitotoxicity Models Measure therapeutic endpoints in animal models with excitotoxic pathology.
- Liver Disease Animal Models Measure therapeutic endpoints in animal models with liver disease.
- Liver Fibrosis Models Measure liver fibrosis using therapeutic endpoints such as collagen assessment, TUNEL staining and inflammatory markers.
- Morris Water Maze Investigate spatial learning and memory in rodents.
- Neuroscience Models Test therapeutic efficacy of drug candidate in neurological disease model.
- Ob/ob Mouse Use a single animal species to create one or more disease models obesity and angiogenesis.
- Obese Mice Use a single animal species to create one or more disease models for diet-induced obesity and type II diabetes.
- Olfactory Testing Models Measure therapeutic endpoints in animal models of olfactory function.
- Parkinson's Disease Models Measure therapeutic endpoints in animal models of Parkinson's disease.
- Schizophrenia Models Measure therapeutic endpoints in animal models of schizophrenia.
- Spinal Cord Injury Models Measure therapeutic endpoints in models of spinal cord injury.
- Stroke Models Measure therapeutic endpoints in animal models of stroke.
DNA & RNA
- Cell Free DNA Assay Detect known mutations and discover new ones in cell-free plasma DNA.
- CRISPR Using advanced CRISPR technology, add or delete base pairs at a specifically targeted DNA loci.
- DNA Mutagenesis Introduce insertions, deletions and substitutions into DNA clones.
- qPCR Analysis Measure the accumulation of PCR products in real time.
- Quantitative RT PCR Use quantitative reverse transcription polymerase chain reaction to measure absolute and relative mRNA abundance.
- RNA Extraction Isolate total RNA or mRNA from cells or tissues
Drug Development
- Safety Pharmacology Consulting Consulting services that help with the detection of potential undesirable pharmacodynamic effects of chemical entities on physiological functions.
General in vivo Toxicology
- Mammalian Toxicology Use toxicity testing models to carry out required FDA or REACH safety testing.
- Single Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by a single administration in a 7 day period.
- Single Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by a single administration in a 7 day period.
Human Biological Samples
- Human Organs-On-Chips Use Organs-On-Chips for target identification and validation, target-based screening, and phenotypic screening.
- Human Primary Cells Acquire fresh/frozen human primary cells based on patient demographics, disease stage, history and treatment. Cell Lines typically refer to legacy immortalised cells, that can be cultured and passaged “indefinitely”...
In Vitro ADME
- Conjugate Detection Measure the conjugation of endogenous small molecules to drug candidates after in vivo administration.
- CYP Induction Detect increases in the expression of various isoforms of cytochrome P450 (CYP450).
- CYP Inhibition Assay Assess the inactivation and inhibition of cytochrome P450 (CYP450) in microsomes isolated from primary human hepatocytes or liver.
- CYP Isozyme Mapping Determine the isozymes of cytochrome P450 (CYP450) involved in the metabolism of a drug candidate.
- Cytochrome P450s Assess the inhibition or induction of the various isozymes of cytochrome P450s by drug candidates.
- Drug Drug Interactions Determine whether a substance affects the activity of a drug when both are administered together.
Show all 16 in In Vitro ADME
- Metabolic Stability Measure metabolic vulnerability to drug metabolizing enzymes using cell-free, cell-based and in vivo assays.
- Metabolic Stability in Hepatocytes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver cells.
- Metabolic Stability in Microsomes Assess the susceptibility of drugs to metabolism by Phase I (CYP450) and Phase II enzymes in liver microsomes.
- Metabolite Generation Analyze the formation of drug metabolites after administration of drug to an animal model or patient.
- Ocular Permeability Measure passive diffusion and active transport of drugs across confluent ocular epithelial cells.
- Phase I Metabolism Use enzymes such as cytochrome P450 oxidases to introduce reactive or polar groups into xenobiotics.
- Phase II Metabolism Use transferase enzymes such as glutathione S-transferases to conjugate phase I xenobiotics to polar compounds.
- Plasma Stability Assay Determine degradation rate of drug candidates in plasma.
- Reactive Metabolite Ensure that your drug candidate is not generating toxic reactive metabolites in vivo.
- Skin Permeability Use human skin models to determine transdermal delivery and percutaneous absorption of pre-clinical drugs.
In Vitro Assays
- Apoptosis Assays Detect apoptotic events that lead to programmed cell death.
- Apoptotic Cell Staining Detect apoptotic cells in culture.
- Assay Development Construct or create new assays or modify existing ones.
- Caspase Assay Detect early to mid stage apoptosis or differentiate apoptosis from necrosis.
- Cell Based Assays Apply compounds to cells and test for cellular phenotypes and effects on gene expression
- Cell Proliferation Measure cell number, cell viability and cell division.
Show all 11 in In Vitro Assays
- Endpoint Dilution Assay (TCID50) Assay Determine the viral titer to induce cell death in half the cell population of an inoculated tissue culture.
- Invasion Assays Monitor and quantify the ability of cultured cells to permeate real or artificial biological barriers.
- Lipid Detection Use in vitro methods to identify lipid droplets and any associated proteins.
- Luciferase Reporter Assay Evaluate promoter activity by measuring light output from the luciferase enzyme.
- Reactive Species Assays Use biochemical, cell-based or in vivo assays to detect and evaluate the effects of reactive species.
In Vitro Pharmacology
- In Vitro Diabetes Models Measure insulin stimulation of glucose uptake and metabolism of lipids including cholesterol and triglycerides.
- In Vitro Excitotoxicity Models Use in vitro models to measure therapeutic endpoints associated with excitotoxic pathology.
- In Vitro Hepatotoxicity Assays Use in vitro assays to measure hepatoxicity-related activities.
- In Vitro Hypoxia Models Use in vitro models to measure therapeutic endpoints associated with hypoxia.
- In Vitro Neural Models Use cultured neurons, neuronal progenitor cells and stem cell differentiation to create cellular models of neurological disease.
- In Vitro Oncology Models Use cell-based and biochemical models of cancer.
In Vitro Toxicology
- Cardiotoxicity Evaluate the effect of a compound on heart electrophysiology and muscle function.
- Cytotoxicity Test for effects on cell viability and proliferation
- Cytotoxicity Testing Determine whether a cosmetic product or ingredient is toxic to in vitro cell cultures.
- Hepatocyte Toxicity Assess the cytotoxic effects of pre-clinical compounds on hepatocytes purified from patients and animal models.
In Vivo Pharmacokinetics
- In Vivo PK Consulting Expert advice on pharmacokinetics and how specific drugs affect the body to determine function, effectiveness, dosage size, etc…
- Rat Efficacy Combination Use rat models to determine the anti-cancer efficacy and potential synergy of a drug candidate with a standard drug treatment.
- Rat Efficacy Monotherapy Use rat models to determine the anti-cancer efficacy of a drug candidate compared to a positive control.
- Repetitive Maximum Tolerated Dose (MTD) Mouse Study Use mouse models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
- Repetitive Maximum Tolerated Dose (MTD) Rat Study Use rat models to determine the MTD of a drug candidate by repetitive administrations for 7 days.
Model Development
- Animal Model Development Create new systems for profiling pre-clinical therapeutics, devices, and surgical techniques.
- Human Precision-Cut Liver Slice Model Acquire a fresh phenotypically-accurate model to study human liver behavior.
- Sprague Dawley Rat Use a single animal species to create one or more disease models for cachexia.
- Surgical Models Create new animal models using techniques such as vascular catherization, soft tissue procedures or device implants.
- Zucker Rat Use a single animal species to create one or more disease models for cachexia.
Oncology Models
- Oncology Models Use model organisms to test the therapeutic efficacy of cancer drug candidates.
Other Specialty Toxicology
- Biosafety Testing Consulting Expert advice to conduct safe and responsible biological procedures and practices.
- Phototoxicity Determine whether drug treatment causes light-activated toxic effects.
Protein Sciences
- Bacterial Expression Produce milligram, gram and kilogram amounts of proteins.
REACH Services
- REACH Services Assist in the registration, evaluation and authorization of chemical substances.
Testing Services
- Bacterial Reverse Mutation Assay Test whether a cosmetic product or ingredient causes DNA mutations in bacteria.
- Membrane Permeability (PAMPA) Parallel Artificial Membrane Permeability Assay (PAMPA) - Measure passive diffusion of drugs by the parallel artificial membrane permeation assay.
- Ocular Corrosion Testing Use in vitro models to determine whether a product (or ingredient) can cause ocular corrosion.
- Ocular Irritation Test Use human subjects to determine whether a cosmetic product or ingredient can cause ocular irritation.
- OECD 435: Skin Corrosion Test - Membrane Barrier Method Use in vitro models to determine whether a cosmetic product or ingredient can cause skin corrosion.
- OECD 442C: Direct Peptide Reactivity Assay (DPRA) Determine whether a test article satisfies the protein-binding criterion for skin sensitizers.
Show all 7 in Testing Services
- OECD TG 492: Ocular Irritation Testing Use in vitro skin models to determine whether a product can cause dermal sensitization (e.g. EpiOcular Eye Irritation Test - EIT)
Where it operates
Sites by country, with the cities in each.
-
United States 3 sites
About this supplier
In the supplier's own words, as listed in the Scientist.com network.
WHO WE ARE Born in 2012 from the idea of creating a platform that foster new paradigms of testing including organotypic slice culture for our pharmaceutical, biotechnology, cosmetic and chemical community. What we do: A pre clinical toxicology services laboratory for drug safety evaluation. Yes, we do preclinical screening tests for cosmetic industry. We also do non clinical toxicology testing for chemical manufacturing. Why we do: We understand the risk involved and the time constraints of live science company in developing the product. Cognizant of the fact , we would like to ease...
Show the full description
WHO WE ARE
Born in 2012 from the idea of creating a platform that foster new paradigms of testing including organotypic slice culture for our pharmaceutical, biotechnology, cosmetic and chemical community.
What we do:
A pre clinical toxicology services laboratory for drug safety evaluation. Yes, we do preclinical screening tests for cosmetic industry. We also do non clinical toxicology testing for chemical manufacturing.
Why we do:
We understand the risk involved and the time constraints of live science company in developing the product. Cognizant of the fact , we would like to ease the pain involved by providing service that you would cherish. Customer satisfaction and integrated quality of studies are the driving force for us while we keep the prices affordable. Simply, to fill gap between east coast and west coast toxicology CRO with mid west price.
Mission:
Dedicated to setting a new standard of service for our clients by tailoring the studies as per customer needs to obtain meaningful data aiding to make informed decision making.
Vision:
A dream to make best safety testing possible from mid west and southwest region.
Values:
We are committed to cultivating long-term, mutually rewarding relationships through teamwork; a unique understanding of our client’s needs and advance their innovation to clinical trials.
- Professional associations
- AAPS, OKBio, SOT
- Website
- www.atdrik.com
Work with Drik on Scientist.com
For prices, more details, or to contact Drik, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.